Literature DB >> 14982726

Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease.

Christopher A Baker1, Zhi Yun Lu, Laura Manuelidis.   

Abstract

Foreign infectious agents typically evoke a host immune response. In scrapie and Creutzfeldt-Jakob disease (CJD), no immune response has been detectable. However, many latent or persistent viruses evade immune recognition but still activate inflammatory pathways. Unique microglial responses in late CJD infection that could be part of a host defense mechanism were previously delineated, although changes secondary to neurodegeneration could not be excluded. Data here show these microglial transcriptional changes are detectable in CJD brain beginning at 30 days after innoculation. In addition, 10 other interferon-sensitive genes were similarly upregulated at very early stages of infection. These responses occurred well before abnormal prion protein (PrP) and clinical signs of CJD were detectable. Further analyses in very pure microglia from CJD brain suggested the CJD agent activated signaling pathways distinct from those induced by amyloidogenic proteins (including abnormal PrP). Although increases in interferon-alpha or -beta transcript levels were not seen in cultures or in whole brain, CJD microglia exhibited a potentiated interferon response when challenged with double-stranded RNA. The induction of interferon-sensitive genes without appreciable interferon synthesis was strikingly similar to that seen in some viral infections. These data suggest the CJD agent is recognized as a foreign virus-like entity. Moreover, the early reactive gene expression profiles described here may be useful in preclinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982726      PMCID: PMC4624297          DOI: 10.1080/13550280490261761

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  61 in total

1.  CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1.

Authors:  M Martin; X Romero; M A de la Fuente; V Tovar; N Zapater; E Esplugues; P Pizcueta; J Bosch; P Engel
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

2.  Postexposure prophylaxis against prion disease with a stimulator of innate immunity.

Authors:  Shneh Sethi; Grayson Lipford; Hermann Wagner; Hans Kretzschmar
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

Review 3.  Genetic approaches to the study of Toll-like receptor function.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

4.  Transmission to animals of Creutzfeldt-Jakob disease from human blood.

Authors:  E E Manuelidis; J H Kim; J R Mericangas; L Manuelidis
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

5.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice.

Authors:  J I Kim; W K Ju; J H Choi; E Choi; R I Carp; H M Wisniewski; Y S Kim
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

6.  HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages.

Authors:  Elena Izmailova; Frederic M N Bertley; Qian Huang; Norbert Makori; Christopher J Miller; Richard A Young; Anna Aldovini
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

7.  Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus.

Authors:  F Belardelli; F Vignaux; E Proietti; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Evidence for an early inflammatory response in the central nervous system of mice with scrapie.

Authors:  S Betmouni; V H Perry; J L Gordon
Journal:  Neuroscience       Date:  1996-09       Impact factor: 3.590

10.  Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles.

Authors:  Christopher A Baker; Daniel Martin; Laura Manuelidis
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  24 in total

1.  Agent-specific Shadoo responses in transmissible encephalopathies.

Authors:  Kohtaro Miyazawa; Laura Manuelidis
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-30       Impact factor: 4.147

2.  Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.

Authors:  Terry Kipkorir; Christopher M Colangelo; Laura Manuelidis
Journal:  Proteomics       Date:  2015-06-09       Impact factor: 3.984

3.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Upregulation of interferon-gamma-induced genes during prion infection.

Authors:  Laura R Moody; Allen J Herbst; Judd M Aiken
Journal:  J Toxicol Environ Health A       Date:  2011

5.  Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture.

Authors:  Kohtaro Miyazawa; Kaitlin Emmerling; Laura Manuelidis
Journal:  Virulence       Date:  2011-05-01       Impact factor: 5.882

6.  A versatile prion replication assay in organotypic brain slices.

Authors:  Jeppe Falsig; Christian Julius; Ilan Margalith; Petra Schwarz; Frank L Heppner; Adriano Aguzzi
Journal:  Nat Neurosci       Date:  2007-12-09       Impact factor: 24.884

7.  Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.

Authors:  Alvaro Arjona; Laura Simarro; Florian Islinger; Noriyuki Nishida; Laura Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

8.  Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration.

Authors:  Robert Field; Suzanne Campion; Colleen Warren; Carol Murray; Colm Cunningham
Journal:  Brain Behav Immun       Date:  2010-04-23       Impact factor: 7.217

9.  Protective role of MyD88-independent innate immune responses against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 10.  Prion disease and the innate immune system.

Authors:  Barry M Bradford; Neil A Mabbott
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.